SuperworthXenon Pharmaceuticals market cap XENE
Share price times shares outstanding: what the whole company sells for, since 2014.
- Today, Oct 23, 2026
- $3.4B
- Highest close in our data
- $6.7B
- Jul 2026
Xenon Pharmaceuticals is worth $3.4B at the close on Oct 23, 2026, at $35.34 a share.
That is up 9% over the last year and up 167% over five years.
Its highest close in our data was $6.7B in Jul 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3.4B | $3.1B | $6.7B | −1% |
| 2025 | $3.5B | $2.2B | $3.5B | +17% |
| 2024 | $3B | $2.8B | $3.5B | −2% |
| 2023 | $3B | $1.9B | $3B | +22% |
| 2022 | $2.5B | $1.3B | $2.5B | +53% |
| 2021 | $1.6B | $502.4M | $1.6B | +199% |
| 2020 | $538.4M | $340.2M | $538.4M | +56% |
| 2019 | $345.6M | $173.4M | $360.9M | +131% |
| 2018 | $149.4M | $50.4M | $274.5M | +193% |
| 2017 | $50.9M | $41.4M | $153.9M | −63% |
| 2016 | $137.8M | $89.4M | $147.6M | +19% |
| 2015 | $115.6M | $110.6M | $310.1M | −52% |
| 2014 | $241.8M | $221.2M | $241.8M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Xenon Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| XENEXenon Pharmaceuticals | $3.4B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.1B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.3B |
| HRMYHarmony Biosciences | $2.1B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| Peer median | $3.9B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Xenon Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.